Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice

Suissa, S; Dell'Aniello, S; Ernst, P

Suissa, S (reprint author), Jewish Gen Hosp, Ctr Clin Epidemiol, 3755 Cote St Catherine,H-461, Montreal, PQ H3T 1E2, Canada.

CHEST, 2019; 155 (6): 1158

Abstract

BACKGROUND: Long-acting beta(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are recommended as initial maintenance treatments for ......

Full Text Link